UBS Group AG - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$214,422
+50.1%
22,266
+40.3%
0.00%
Q2 2023$142,821
+169.4%
15,869
+135.2%
0.00%
Q1 2023$53,023
-18.6%
6,746
-30.0%
0.00%
Q4 2022$65,126
+261.8%
9,634
+682.0%
0.00%
Q3 2022$18,000
+80.0%
1,232
+15.8%
0.00%
Q2 2022$10,000
-98.4%
1,064
-97.5%
0.00%
Q1 2022$634,000
-10.5%
42,993
-19.7%
0.00%
Q4 2021$708,000
+22.1%
53,563
+61.2%
0.00%
Q3 2021$580,000
+457.7%
33,228
+668.8%
0.00%
Q2 2021$104,000
-62.5%
4,322
-59.9%
0.00%
Q1 2021$277,000
+714.7%
10,776
+509.2%
0.00%
Q4 2020$34,000
+240.0%
1,769
+133.4%
0.00%
Q3 2020$10,000
-80.8%
758
-82.4%
0.00%
Q2 2020$52,000
-8.8%
4,315
-42.6%
0.00%
Q1 2020$57,000
-81.6%
7,511
-56.8%
0.00%
Q4 2019$310,000
+150.0%
17,393
+62.4%
0.00%
Q3 2019$124,000
+163.8%
10,711
+408.6%
0.00%
Q2 2019$47,000
+235.7%
2,106
+334.2%
0.00%
Q1 2019$14,0000.0%485
-26.5%
0.00%
Q3 2018$14,000
-44.0%
660
-78.8%
0.00%
Q2 2018$25,000
+2400.0%
3,114
+2047.6%
0.00%
Q1 2018$1,000
-93.8%
145
-90.9%
0.00%
Q4 2017$16,000
+45.5%
1,591
+5.6%
0.00%
Q2 2017$11,000
-38.9%
1,506
-34.7%
0.00%
Q1 2017$18,000
+200.0%
2,307
+153.8%
0.00%
Q4 2016$6,0009090.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders